Developments in t cell based cancer immunotherapies / 
edited by Paolo A. Ascierto, David F. Stroncek, Ena Wang. 
 - 1st ed. 2015. 
 - xv, 305 páginas :  26 ilustraciones en color. 
 - Cancer Drug Discovery and Development,  2196-9906 .
<br/><br/> Springer eBooks 
<br/><br/>1 New insight of peptide vaccination in cancer immunotherapy -- 2 The determinants of T cell function for effective anticancer vaccine -- 3 T cell fate in the tumor microenvironment -- 4 T cell receptor avidity and affinity and tumor specific TCR engineer  -- 5 Host genetic variation and somatic alteration associated with favorable or compromised T cell function -- 6 Production of Clinical T Cell Therapies -- 7 Clinical success of adoptive cell transfer therapy using tumor infiltrating lymphocytes.-8 Harnessing stem cell-like memory T cells for adoptive cell transfer therapy of cancer  -- 9 T cell blockade- anti-CTLA4 immunotherapy against cancer and Abscopal effect in combination therapy -- 10 T cell modulation- anti-OD-1 antibodies for the treatment of cancer -- 11 T cell based therapies in combination with other procedures -- 12 Chimeric antigen receptor T cells CD19 CAR -- 13 Hematopoietic Stem Cell transplantation as immune therapy of malignancies. 
<br/><br/><label>ISBN: </label>9783319211671 
<br/><br/><label>LC Class. No.: </label>RC261-271